Skip to Content
AP National Business

J&J tops 4Q earnings forecasts but misses on revenue

<i></i><br/>
KMIZ

By
Published 6:13 AM

By TOM MURPHY
AP Health Writer

Johnson & Johnson edged past Wall Street’s fourth quarter earnings expectations, helped by growing pharmaceutical sales, but the health care giant’s revenue fell short. The world’s biggest maker of health care products also debuted a 2022 forecast on Tuesday that came in higher than expectations. J&J expects to post adjusted earnings of $10.40 to $10.60 her share this year. Analysts expect, on average, earnings of $10.35 per share, according to FactSet. In the fourth quarter, New Brunswick, New Jersey-based Johnson & Johnson earned $4.74 billion, while sales grew 10% to $24.8 billion.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content